ENLIGHT and other EU-funded projects in hadron therapy.
Following impressive results from early phase trials in Japan and Germany, there is a current expansion in European hadron therapy. This article summarises present European Union-funded projects for research and co-ordination of hadron therapy across Europe. Our primary focus will be on the research questions associated with carbon ion treatment of cancer, but these considerations are also applicable to treatments using proton beams and other light ions. The challenges inherent in this new form of radiotherapy require maximum interdisciplinary co-ordination. On the basis of its successful track record in particle and accelerator physics, the internationally funded CERN laboratories (otherwise known as the European Organisation for Nuclear Research) have been instrumental in promoting collaborations for research purposes in this area of radiation oncology. There will soon be increased opportunities for referral of patients across Europe for hadron therapy. Oncologists should be aware of these developments, which confer enhanced prospects for better cancer cure rates as well as improved quality of life in many cancer patients.
Dosanjh
M
M
CERN, 1211 Geneva 23, Switzerland. Manjit.Dosanjh@cern.ch
Jones
B
B
Mayer
R
R
Meyer
R
R
D004307:Dose-Response Relationship, Radiation; D005060:Europe; D063193:Heavy Ion Radiotherapy; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D018787:Radiation Oncology / Q000592:standards*; D012062:Relative Biological Effectiveness